Schmitz B, Thiele J, Witte O, Kaufmann R, Wickenhauser C, Fischer R
Institute of Pathology, University of Cologne, Germany.
Eur J Haematol. 1995 Jul;55(1):24-32. doi: 10.1111/j.1600-0609.1995.tb00229.x.
The evolution of myelofibrosis accompanying chronic myeloproliferative disorders (CMPDs) is often linked with megakaryopoiesis. However, it is not known whether or to what extent megakaryocytes of normal human bone marrow are capable of stimulating fibroblast growth. For this reason, an in vitro study was performed to elucidate possible cytokine-dependent interactions between megakaryocytes and fibroblasts derived from healthy volunteers. Fibroblast growth was significantly promoted by the presence of megakaryocytes and modulated by additional application of various cytokines. While recombinant human (rh) interleukin (IL)-1 alpha had no obvious effect on fibroblast proliferation, a slight increase was detected on adding granulocyte-macrophage colony stimulating factor (rhGM-CSF). Application of rhIL-3 caused a significant increase in the number of fibroblasts. In contrast, administration of rhIL-11 suppressed the megakaryocyte-dependent growth-promoting effect and co-stimulation with rhIL-3 led to a significant decrease of fibroblast number in comparison to rhIL-3-stimulated co-cultures. Inhibition of cell-cell contact in unstimulated, as well as in rhIL-3-stimulated co-cultured led to a conspicuous impairment of fibroblast growth. A similar effect was observed when neutralizing antibodies directed against platelet-derived growth factor (PDGF) and transforming growth factor (TGF)beta 1 were added to rhIL-3-stimulated cultures. Our findings are in keeping with the assumption that interactions between megakaryocytes and fibroblasts involve in cytokine-mediated functional network regulated by factors such as spatial relationship, cytokine stimulation, and low concentrations of mediators, particularly PDGF and TGF beta. In this complex system rhIL-3 seems to play a crucial role in the promotion of these various interrelationships.
骨髓纤维化伴随慢性骨髓增殖性疾病(CMPDs)的演变通常与巨核细胞生成有关。然而,尚不清楚正常人骨髓中的巨核细胞是否能够刺激成纤维细胞生长以及在何种程度上能够刺激成纤维细胞生长。因此,进行了一项体外研究,以阐明来自健康志愿者的巨核细胞与成纤维细胞之间可能存在的细胞因子依赖性相互作用。巨核细胞的存在显著促进了成纤维细胞的生长,并受到各种细胞因子额外应用的调节。虽然重组人(rh)白细胞介素(IL)-1α对成纤维细胞增殖没有明显影响,但添加粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)时检测到轻微增加。rhIL-3的应用导致成纤维细胞数量显著增加。相反,与rhIL-3刺激的共培养物相比,rhIL-11的施用抑制了巨核细胞依赖性生长促进作用,并且与rhIL-3共同刺激导致成纤维细胞数量显著减少。在未刺激的以及rhIL-3刺激的共培养物中抑制细胞-细胞接触导致成纤维细胞生长明显受损。当将针对血小板衍生生长因子(PDGF)和转化生长因子(TGF)β1的中和抗体添加到rhIL-3刺激的培养物中时,观察到类似的效果。我们的研究结果符合这样的假设,即巨核细胞与成纤维细胞之间的相互作用涉及由空间关系、细胞因子刺激和低浓度介质(特别是PDGF和TGFβ)等因素调节的细胞因子介导的功能网络。在这个复杂的系统中,rhIL-3似乎在促进这些各种相互关系中起着关键作用。